{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:19:55Z","timestamp":1793621995241,"version":"4.5.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020573","name":"Tel Aviv University Sagol School of Neuroscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020573","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1758\/19 & 1906\/24"],"award-info":[{"award-number":["1758\/19 & 1906\/24"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.neo.2025.101182","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T14:32:30Z","timestamp":1748010750000},"page":"101182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Escitalopram facilitates tumor growth and metastasis in rodents: Is it safe?"],"prefix":"10.1016","volume":"66","author":[{"given":"Yosi","family":"Azan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Margalit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3374-5052","authenticated-orcid":false,"given":"Elad","family":"Sandbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravid","family":"Doron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Sorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Rosenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5105-9198","authenticated-orcid":false,"given":"Avital Luba","family":"Plosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avital","family":"Gilam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabel","family":"Eckerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noam","family":"Shomron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-0678","authenticated-orcid":false,"given":"Shamgar","family":"Ben-Eliyahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2025.101182_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1000000","article-title":"Antidepressant use pattern and disparities among cancer patients in the United States","volume":"10","author":"Zou","year":"2022","journal-title":"Front. Public health"},{"issue":"11","key":"10.1016\/j.neo.2025.101182_bib0002","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/FPC.0b013e32833132cb","article-title":"Selective serotonin reuptake inhibitors pathway","volume":"19","author":"Sangkuhl","year":"2009","journal-title":"Pharmacogenetics Genom."},{"issue":"5","key":"10.1016\/j.neo.2025.101182_bib0003","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neo.2025.101182_bib0004","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0278-5846(02)00338-X","article-title":"Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review","volume":"27","author":"Vaswani","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neo.2025.101182_bib0005","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.2174\/092986712800099749","article-title":"Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions","volume":"19","author":"Mandrioli","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neo.2025.101182_bib0006","article-title":"Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients","volume":"27","author":"Boursi","year":"2018","journal-title":"Eur. J. Cancer Care"},{"key":"10.1016\/j.neo.2025.101182_bib0007","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13058-017-0928-0","article-title":"Selective serotonin reuptake inhibitor use and breast cancer survival: a population-based cohort study","volume":"20","author":"Busby","year":"2018","journal-title":"Breast Cancer Res.: BCR"},{"key":"10.1016\/j.neo.2025.101182_bib0008","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.biopha.2017.01.024","article-title":"A current perspective on the oncopreventive and oncolytic properties of selective serotonin reuptake inhibitors","volume":"87","author":"Radin","year":"2017","journal-title":"Biomed. Pharmacother. = Biomed. pharmacother."},{"key":"10.1016\/j.neo.2025.101182_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052711","article-title":"Complex effects of Sertraline and Citalopram on In vitro murine breast cancer proliferation and on In vivo progression and anxiety level","volume":"23","author":"Taler","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neo.2025.101182_bib0010","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/cancers12051184","article-title":"The association between selective serotonin reuptake inhibitors (SSRIs) use and the risk of bladder cancer: a nationwide population-based cohort study","volume":"12","author":"Liu","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2025.101182_bib0011","first-page":"209","article-title":"Escitalopram: a new SSRI for the treatment of depression in primary care","volume":"4","author":"Culpepper","year":"2002","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.neo.2025.101182_bib0012","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bja\/aeq164","article-title":"Effect of anaesthetic technique and other perioperative factors on cancer recurrence","volume":"105","author":"Snyder","year":"2010","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.neo.2025.101182_bib0013","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","article-title":"Exploiting the critical perioperative period to improve long-term cancer outcomes","volume":"12","author":"Horowitz","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.neo.2025.101182_bib0014","series-title":"Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability","author":"Kirino","year":"2012"},{"issue":"S1","key":"10.1016\/j.neo.2025.101182_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1017\/S1092852900028583","article-title":"Escitalopram: a second-generation SSRI","volume":"7","author":"Owens","year":"2002","journal-title":"CNS Spectr."},{"issue":"22","key":"10.1016\/j.neo.2025.101182_bib0016","doi-asserted-by":"crossref","first-page":"7594","DOI":"10.3390\/molecules28227594","article-title":"Antidepressants as autophagy modulators for cancer therapy","volume":"28","author":"He","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.neo.2025.101182_bib0017","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1517\/14656566.7.4.429","article-title":"Managing depressive and anxiety disorders with escitalopram","volume":"7","author":"Thase","year":"2006","journal-title":"Expert opin. Pharmacother."},{"issue":"22","key":"10.1016\/j.neo.2025.101182_bib0018","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.8891","article-title":"SSRI use and clinical outcomes in epithelial ovarian cancer","volume":"7","author":"Christensen","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.neo.2025.101182_bib0019","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ijc.33307","article-title":"Association between selective serotonin reuptake inhibitors and kidney cancer risk: a nationwide population-based cohort study","volume":"148","author":"Lee","year":"2020","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.neo.2025.101182_bib0020","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/lary.30249","article-title":"De-novo depression, prophylactic antidepressant, and survival in patients with head and neck cancer","volume":"133","author":"Panwar","year":"2022","journal-title":"Laryngoscope"},{"issue":"16","key":"10.1016\/j.neo.2025.101182_bib0021","doi-asserted-by":"crossref","first-page":"9247","DOI":"10.3390\/ijms23169247","article-title":"Protective effect of escitalopram on hepatocellular carcinoma by inducing autophagy","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2025.101182_bib0022","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232416179","article-title":"Synergistic effects of the combinational use of Escitalopram oxalate and 5-fluorouracil on the inhibition of gastric cancer SNU-1 cells","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.neo.2025.101182_bib0023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241612630","article-title":"Combined administration of escitalopram oxalate and nivolumab exhibits synergistic growth-inhibitory effects on liver cancer cells through inducing apoptosis","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neo.2025.101182_bib0024","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1601-5215.2011.00550.x","article-title":"Escitalopram oxalate, a selective serotonin reuptake inhibitor, exhibits cytotoxic and apoptotic effects in glioma C6 cells","volume":"23","author":"Dikmen","year":"2011","journal-title":"Acta Neuropsychiatr."},{"issue":"26","key":"10.1016\/j.neo.2025.101182_bib0025","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.17050","article-title":"Assessment of citalopram and escitalopram on neuroblastoma cell lines: cell toxicity and gene modulation","volume":"8","author":"Sakka","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2025.101182_bib0026","doi-asserted-by":"crossref","DOI":"10.3892\/ol.2017.7687","article-title":"Escitalopram oxalate inhibits proliferation and migration and induces apoptosis in non-small cell lung cancer cells","author":"Yuan","year":"2017","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.neo.2025.101182_bib0027","article-title":"Immunomodulatory effects mediated by serotonin","volume":"2015","author":"Arreola","year":"2015","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.neo.2025.101182_bib0028","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.intimp.2014.02.030","article-title":"Selective serotonin reuptake inhibitors as a novel class of immunosuppressants","volume":"20","author":"Gobin","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.neo.2025.101182_bib0029","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000054278","article-title":"Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release","volume":"8","author":"Pellegrino","year":"2000","journal-title":"Neuroimmunomodulation"},{"issue":"4","key":"10.1016\/j.neo.2025.101182_bib0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neo.2025.101182_bib0031","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","article-title":"Platelets and cancer: a casual or causal relationship: revisited","volume":"33","author":"Menter","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.neo.2025.101182_bib0032","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jneuroim.2017.05.020","article-title":"Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge","volume":"309","author":"Avitsur","year":"2017","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neo.2025.101182_bib0033","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/jdn.10224","article-title":"The protective effects of escitalopram on synaptic plasticity in the CA1 region of chronically stressed and non-stressed male rats","volume":"82","author":"Farahbakhsh","year":"2022","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.neo.2025.101182_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112280","article-title":"Anti-depressant activity of erythrina variegata bark extract and regulation of monoamine oxidase activities in mice","volume":"248","author":"Martins","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.neo.2025.101182_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-017-0357-0","article-title":"Effects of escitalopram and paroxetine on mTORC1 signaling in the rat hippocampus under chronic restraint stress","volume":"18","author":"Seo","year":"2017","journal-title":"BMC Neurosci."},{"issue":"17","key":"10.1016\/j.neo.2025.101182_bib0036","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1071\/RD22033","article-title":"Congenital anomalies and spontaneous abortion in mice resulting from the use of escitalopram","volume":"34","author":"Sestario","year":"2022","journal-title":"Reprod. Fertil. Dev."},{"key":"10.1016\/j.neo.2025.101182_bib0037","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jad.2023.05.085","article-title":"The antidepressant-like effects of escitalopram in mice require salt-inducible kinase 1 and CREB-regulated transcription co-activator 1 in the paraventricular nucleus of the hypothalamus","volume":"338","author":"Shi","year":"2023","journal-title":"J. Affect. Disord."},{"issue":"12","key":"10.1016\/j.neo.2025.101182_bib0038","first-page":"1460","article-title":"Therapeutic effects of exercise-accompanied escitalopram on synaptic potency and long-term plasticity in the hippocampal CA1 area in rats under chronic restraint stress","volume":"25","author":"Zamani","year":"2022","journal-title":"DOAJ (DOAJ: Dir. Open Access J.)"},{"key":"10.1016\/j.neo.2025.101182_bib0039","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/0960327112462728","article-title":"Effect of escitalopram on cardiomyopathy-induced anxiety in mice","volume":"32","author":"Anwar","year":"2013","journal-title":"Hum. Exp. Toxicol."},{"issue":"4","key":"10.1016\/j.neo.2025.101182_bib0040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s11307-023-01825-6","article-title":"Effects of escitalopram on the functional neural circuits in an animal model of adolescent depression","volume":"25","author":"Oh","year":"2023","journal-title":"Mol. Imaging Biol."},{"issue":"4","key":"10.1016\/j.neo.2025.101182_bib0041","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200746040-00002","article-title":"The clinical pharmacokinetics of Escitalopram","volume":"46","author":"Rao","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.neo.2025.101182_bib0042","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1176\/appi.ajp.158.11.1843","article-title":"Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [11C]DASB PET imaging study","volume":"158","author":"Meyer","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neo.2025.101182_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.972141","article-title":"Systematic review and meta-analysis on the therapeutic reference range for escitalopram: blood concentrations, clinical effects and serotonin transporter occupancy","volume":"13","author":"Eichentopf","year":"2022","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neo.2025.101182_bib0044","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bjp.2008.243","article-title":"Prediction of clinical response based on pharmacokinetic\/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice","volume":"155","author":"Kreilgaard","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neo.2025.101182_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuropharm.2015.12.009","article-title":"P-glycoprotein differentially affects escitalopram, levomilnacipran, vilazodone and vortioxetine transport at the mouse blood\u2013brain barrier in vivo","volume":"103","author":"Bundgaard","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neo.2025.101182_bib0046","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1742-7843.2006.00029.x","article-title":"Pharmacokinetic\/pharmacodynamic feedback modelling of the functional corticosterone response in rats after acute treatment with escitalopram","volume":"100","author":"Bundgaard","year":"2007","journal-title":"Basic clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.neo.2025.101182_bib0047","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/sj.bjp.0705800","article-title":"Effects of chronic treatment with escitalopram or citalopram on extracellular 5-HT in the prefrontal cortex of rats: role of 5-HT1A receptors","volume":"142","author":"Ceglia","year":"2004","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neo.2025.101182_bib0048","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3181\/00379727-77-18779","article-title":"Sustained enhanced growth of carcinoma EO771 in C57 black mice","volume":"77","author":"Casey","year":"1951","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neo.2025.101182_bib0050","author":"Corbett"},{"issue":"2","key":"10.1016\/j.neo.2025.101182_bib0051","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbi.2004.07.004","article-title":"Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a \u03b2-adrenergic antagonist and a prostaglandin synthesis inhibitor","volume":"19","author":"Melamed","year":"2004","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neo.2025.101182_bib0052","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbi.2016.05.017","article-title":"Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through \u03b2-adrenoceptors blockade and COX2 inhibition","volume":"58","author":"Sorski","year":"2016","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.neo.2025.101182_bib0053","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/IJGC:29:1:37","article-title":"A novel, clinically relevant animal model of metastatic pancreatic adenocarcinoma Biology and Therapy","volume":"29","author":"Wang","year":"2001","journal-title":"Int. J. Gastrointest. Cancer"},{"key":"10.1016\/j.neo.2025.101182_bib0054","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1213\/01.ANE.0000082995.44040.07","article-title":"Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, Thiopental, and Halothane, but not by propofol: mediating mechanisms and prophylactic measures","volume":"97","author":"Melamed","year":"2003","journal-title":"Anesth. Analg."},{"issue":"Suppl","key":"10.1016\/j.neo.2025.101182_bib0055","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.bbi.2012.03.006","article-title":"Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement","volume":"30","author":"Neeman","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.neo.2025.101182_bib0056","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1158\/1078-0432.CCR-12-1087","article-title":"A new approach to reducing postsurgical cancer recurrence: perioperative targeting of catecholamines and prostaglandins","volume":"18","author":"Neeman","year":"2012","journal-title":"Clin. cancer res.: off. j. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.neo.2025.101182_bib0057","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41568-021-00395-5","article-title":"Stress and cancer: mechanisms, significance and future directions","volume":"21","author":"Eckerling","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2025.101182_bib0058","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.1002\/cam4.2474","article-title":"Are 90% of deaths from cancer caused by metastases?","volume":"8","author":"Dillekas","year":"2019","journal-title":"Cancer Med."},{"issue":"11","key":"10.1016\/j.neo.2025.101182_bib0059","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.trecan.2020.06.004","article-title":"Tumor excision as a metastatic Russian roulette: perioperative interventions to improve long-term survival of cancer patients","volume":"6","author":"Ben-Eliyahu","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.neo.2025.101182_bib0060","first-page":"1016","article-title":"Revisiting the hallmarks of cancer","volume":"7","author":"Fouad","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.neo.2025.101182_bib0061","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.psyneuen.2015.01.008","article-title":"A shift toward T helper 2 responses and an increase in modulators of innate immunity in depressed patients treated with escitalopram","volume":"53","author":"Ho","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neo.2025.101182_bib0062","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2217\/fon.10.142","article-title":"Impact of stress on cancer metastasis","volume":"6","author":"Moreno-Smith","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.neo.2025.101182_bib0063","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S1470-2045(04)01597-9","article-title":"Stress, depression, the immune system, and cancer","volume":"5","author":"Reiche","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.neo.2025.101182_bib0064","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1185\/030079906X148319","article-title":"The onset of effect for escitalopram and its relevance for the clinical management of depression","volume":"22","author":"Wade","year":"2006","journal-title":"Curr. Med. Res. Opin."},{"issue":"6","key":"10.1016\/j.neo.2025.101182_bib0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1192\/bjp.bp.107.048371","article-title":"Antidepressant-induced jitteriness\/anxiety syndrome: systematic review","volume":"194","author":"Sinclair","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.neo.2025.101182_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109734","article-title":"Acute anxiogenic effects of escitalopram are associated with mild alterations in d-amphetamine-induced behavior and social approach evoked by playback of 50-kHz ultrasonic vocalizations in rats","volume":"241","author":"Willadsen","year":"2023","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neo.2025.101182_bib0067","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/da.20917","article-title":"What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?","volume":"29","author":"Gollan","year":"2012","journal-title":"Depress. Anxiety"},{"issue":"3","key":"10.1016\/j.neo.2025.101182_bib0068","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/WNF.0000000000000139","article-title":"Characteristics of escitalopram discontinuation Syndrome","volume":"39","author":"Yasui-Furukori","year":"2016","journal-title":"Clin. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.neo.2025.101182_bib0069","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.mehy.2011.08.035","article-title":"Tapering antidepressants: is 3 months slow enough?","volume":"77","author":"Phelps","year":"2011","journal-title":"Med. Hypotheses"},{"issue":"8","key":"10.1016\/j.neo.2025.101182_bib0070","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial","volume":"26","author":"Hiller","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.neo.2025.101182_bib0071","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1245\/s10434-008-9890-5","article-title":"Perioperative use of \u03b2-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis","volume":"15","author":"Benish","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.neo.2025.101182_bib0072","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-19-2641","article-title":"Preoperative \u03b2-blockade with propranolol reduces biomarkers of metastasis in breast cancer: a phase II randomized trial","volume":"26","author":"Hiller","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2025.101182_bib0073","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/path.6020","article-title":"Targeting the \u03b22-adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism","volume":"259","author":"Satilmis","year":"2023","journal-title":"J. Pathol."},{"issue":"16","key":"10.1016\/j.neo.2025.101182_bib0074","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","article-title":"Perioperative COX-2 and \u03b2-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial","volume":"23","author":"Shaashua","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"10.1016\/j.neo.2025.101182_bib0075","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1002\/cncr.32950","article-title":"Perioperative COX2 and \u03b2-adrenergic blockade improves biomarkers of tumor metastasis, immunity, and inflammation in colorectal cancer: a randomized controlled trial","volume":"126","author":"Haldar","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.neo.2025.101182_bib0076","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbi.2024.02.009","article-title":"Peri-operative individually tailored psychological intervention in breast cancer patients improves psychological indices and molecular biomarkers of metastasis in excised tumors","volume":"117","author":"Hanalis-Miller","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neo.2025.101182_bib0077","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"issue":"6","key":"10.1016\/j.neo.2025.101182_bib0078","first-page":"1008","article-title":"Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice","volume":"121","author":"Duerschmied","year":"2013","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"10.1016\/j.neo.2025.101182_bib0079","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/138955710791112587","article-title":"Latest advancements on serotonin and dopamine transporters in lymphocytes","volume":"10","author":"Marazziti","year":"2010","journal-title":"Mini rev. Med. Chem."},{"key":"10.1016\/j.neo.2025.101182_bib0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/brbi.1998.0532","article-title":"Role of serotonin in the immune system and in neuroimmune interactions","volume":"12","author":"Mossner","year":"1998","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.neo.2025.101182_bib0081","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1566524015666150114113411","article-title":"Serotonin and cancer: what is the link?","volume":"15","author":"Sarrouilhe","year":"2015","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.neo.2025.101182_bib0082","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/ijms22031268","article-title":"Serotonin pathway in cancer","volume":"22","author":"Balakrishna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.neo.2025.101182_bib0083","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.4049\/jimmunol.0903301","article-title":"Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a \u0392-adrenergic antagonist and a cyclooxygenase-2 inhibitor","volume":"184","author":"Glasner","year":"2010","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.neo.2025.101182_bib0084","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1158\/1078-0432.CCR-17-0152","article-title":"Perioperative COX-2 and \u0392-adrenergic blockade improves metastatic biomarkers in breast cancer patients in a phase-II randomized trial","volume":"23","author":"Shaashua","year":"2017","journal-title":"Clin. Cancer Res."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558625000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:00:47Z","timestamp":1778616047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558625000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":83,"alternative-id":["S1476558625000612"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2025.101182","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Escitalopram facilitates tumor growth and metastasis in rodents: Is it safe?","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2025.101182","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101182"}}